X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Tags:
What you should know is that while the Pfizer, Moderna and Johnson & Johnson vaccines are all working well to prevent serious COVID-19 cases and... [Read More]
Thumbnail
A booster dose of the COVID-19 vaccine restored efficacy to 95.6 per cent against the virus, including the Delta variant, data released by the company... [Read More]
FDA authorizes more boosters, Pfizer booster shot study, demand for virus testing. Here's the latest on the pandemic. [Read More]
A booster was shown to be 95.6% effective against symptomatic COVID in a Pfizer Inc. and BioNTech study. [Read More]
Pfizer Inc. and BioNTech SE said a booster shot of their Covid-19 vaccine restored full... [Read More]
The CDC's influential vaccines advisory committee recommended both Pfizer and Merck's new pneumococcal vaccines for older adults, surprising analysts. [Read More]
Thomas Kienzle/AFP via Getty Images ... [Read More]
New Phase III clinical trial data from Pfizer-BioNTech found that a booster dose of their COVID-19 vaccine was 95.6% effective against infection, up from 84%... [Read More]
Thumbnail
The company said that in a study, boosters cut down the number of breakthrough infections among fully vaccinated people by more than 95 percent. [Read More]
'These are the first efficacy results from any randomized, controlled Covid-19 vaccine booster trial.' Pfizer and BioNTech said. [Read More]
The companies said the trial, which has not been peer-reviewed, tested 10,000 participants aged 16 and older, and found that the booster shot had a... [Read More]
Thursday on CNN's "New Day," U.S. Surgeon General Vivek Murthy sounded off on masks for children as the White House prepares for the Pfizer coronavirus vaccine... [Read More]
Children ages 5 to 11 will soon be able to get a COVID-19 shot at their pediatrician's office, local pharmacy and potentially even their school,... [Read More]
The Pfizer/BioNTech COVID-19 vaccine is highly effective at preventing infection and symptomatic disease from the Delta variant among 12- to 18-year-olds, research conducted in Israel... [Read More]
There was a flurry of positive news on vaccine boosters Thursday, as the Centers for Disease Control and Prevention gathered to discuss which patient groups... [Read More]
There was a flurry of positive news on vaccine boosters Thursday, as the Centers for Disease Control and Prevention gathered to discuss which patient groups... [Read More]
There was a flurry of positive news on vaccine boosters Thursday, as the Centers for Disease Control and Prevention gathered to discuss which patient groups... [Read More]
There was a flurry of positive news on vaccine boosters Thursday, as the Centers for Disease Control and Prevention gathered to discuss which patient groups... [Read More]
BERLIN (Reuters) -A booster dose of the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech SE restored efficacy to 95.6% against the virus,... [Read More]
A terceira dose da vacina contra a Covid-19 da Pfizer/BioNTech tem eficácia de 95,6% contra as formas sintomáticas da doença. É o que mostra um... [Read More]
Loading...
Save As
Preview
Preview